1. Home
  2. IHS vs PLSE Comparison

IHS vs PLSE Comparison

Compare IHS & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IHS
  • PLSE
  • Stock Information
  • Founded
  • IHS 2001
  • PLSE 2014
  • Country
  • IHS United Kingdom
  • PLSE United States
  • Employees
  • IHS N/A
  • PLSE N/A
  • Industry
  • IHS Telecommunications Equipment
  • PLSE Medical/Dental Instruments
  • Sector
  • IHS Telecommunications
  • PLSE Health Care
  • Exchange
  • IHS Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • IHS 979.2M
  • PLSE 1.0B
  • IPO Year
  • IHS 2021
  • PLSE 2016
  • Fundamental
  • Price
  • IHS $2.84
  • PLSE $17.98
  • Analyst Decision
  • IHS Strong Buy
  • PLSE
  • Analyst Count
  • IHS 7
  • PLSE 0
  • Target Price
  • IHS $8.93
  • PLSE N/A
  • AVG Volume (30 Days)
  • IHS 243.3K
  • PLSE 136.2K
  • Earning Date
  • IHS 11-12-2024
  • PLSE 10-30-2024
  • Dividend Yield
  • IHS N/A
  • PLSE N/A
  • EPS Growth
  • IHS N/A
  • PLSE N/A
  • EPS
  • IHS N/A
  • PLSE N/A
  • Revenue
  • IHS $1,829,928,000.00
  • PLSE N/A
  • Revenue This Year
  • IHS N/A
  • PLSE N/A
  • Revenue Next Year
  • IHS $2.40
  • PLSE N/A
  • P/E Ratio
  • IHS N/A
  • PLSE N/A
  • Revenue Growth
  • IHS N/A
  • PLSE N/A
  • 52 Week Low
  • IHS $2.18
  • PLSE $4.57
  • 52 Week High
  • IHS $5.78
  • PLSE $22.69
  • Technical
  • Relative Strength Index (RSI)
  • IHS 44.48
  • PLSE 54.90
  • Support Level
  • IHS $2.67
  • PLSE $14.06
  • Resistance Level
  • IHS $3.02
  • PLSE $18.09
  • Average True Range (ATR)
  • IHS 0.11
  • PLSE 1.35
  • MACD
  • IHS -0.00
  • PLSE 0.07
  • Stochastic Oscillator
  • IHS 63.41
  • PLSE 89.91

About IHS IHS Holding Limited

IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, most of who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: